Sun Pharma Advanced Research Company Ltd

NSE: SPARC · BSE: 532872 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹212.73
Market cap: ₹6,904 Cr
Revenue (annual): ₹1,879 Cr
Net profit (annual): ₹1,553 Cr
P/E (TTM): 4.2×Sector 43.8×
Promoter holding: 65.67%+0.00% QoQ
FII holding: 3.74%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Promoter Reclassification 1 Legal & Regulatory 1 Financial Results 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

4 Oct 2026 12:38 IST BSE

Legal & Regulatory

Sun Pharma Advanced Research Company Legal & Regulatory

The company secured a favorable CESTAT order confirming its entitlement to a Rs. 27.51 Crore CENVAT credit refund. This concludes the litigation in the company's favor.

Value: ₹27.51 Cr

Open announcement → Read the filing ↗